Evaluation of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device
Heavy Menstrual Bleeding
About this trial
This is an interventional treatment trial for Heavy Menstrual Bleeding focused on measuring endometrial ablation, heavy menstrual bleeding, novosure
Eligibility Criteria
Inclusion Criteria:
- Women with no desire to preserve their fertility who have heavy menstrual bleeding without organic pathology (DUB) of more than six months duration
- Associated functional disability (negative impact on life quality).
- Lack of response to medical treatment.
- Prepared to undergo surgical treatment without general anaesthesia
Exclusion Criteria:
- Women under 25 years
- Suspected genital tract infection
- Uterine pathology including endometrial pathology on endometrial biopsy (e.g. endometrial hyperplasia or carcinoma) and structural lesions (e.g. uterine malformations, adhesions, polyps, submucous fibroids or extracavity fibroids > 3cm in diameter) as identified on pelvic ultrasound and/or outpatient hysteroscopy.
- Uterine cavity length >11cm
- Adnexal pathology
- Previous open myomectomy or endometrial ablation / resection and classical caesarian section
- Patients considered vulnerable (e.g. current mental illness, emotionally labile, learning difficulties, immaturity)
Sites / Locations
Arms of the Study
Arm 1
Experimental
Endometrial Ablation (4th gen)
A single-centre uncontrolled observational study is proposed. All women presenting to the gynaecology outpatient clinic with heavy menstrual bleeding (HMB) in the absence of recognizable pelvic pathology, as determined by one or all of a normal pelvic ultrasound, hysteroscopy and / or endometrial biopsy, refractory to medical therapy that persists despite treatment with recommended pharmacological agents, who have no desire to preserve their fertility and are willing to have an endometrial ablation will be invited to participate. Eligible women with HMB will undergo RFA G4 endometrial ablation in either an inpatient or outpatient setting according to their preference.